BeiGene strengthens European presence with new office in Basel, Switzerland

China's BeiGene has announced the opening of a new regional office in Basel, Switzerland. BeiGene has built a European o...

May 17, 2022 | Tuesday | News
Japanese life science research market secures Protein Footprinting Products

GenNext Technologies, Inc. (GenNext), in partnership with Kiko Tech Co., Ltd., will provide Flash Oxidation (Fox&tr...

May 17, 2022 | Tuesday | News
Nanoparticles: sometimes the smallest things can have the biggest impact

Over the last 40 years, technological developments at nano scale have increased interest in nanoparticles and their pote...

May 16, 2022 | Monday | Opinion
Study in Hong Kong shows robust antibody generation post-vaccination as compared to natural infection

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of...

May 16, 2022 | Monday | News
Australia launches shared industry vision & blueprint navigating biotech ecosystem

For the first time in 20 years, Australia’s biotechnology sector has united to launch the Biotechnology Blueprint:...

May 16, 2022 | Monday | News
India launches angel investor network to raise Rs 350 Cr investment for biotech startups

To unlock the potential of Indian startups, the Biotechnology Industry Research Assistance Council (BIRAC) has collabora...

May 11, 2022 | Wednesday | News
BioSpectrum Asia launches new job portal- BioSpectrum Jobs

  BioSpectrum Asia, an integrated B2B media platform for the healthcare and bioscience industry in the Asia Pacifi...

May 11, 2022 | Wednesday | News
Singapore-based AUM Biosciences partners with Roche for cancer drug trial

Singapore-based AUM Biosciences has entered into a clinical trial collaboration and supply agreement with Roche to evalu...

May 11, 2022 | Wednesday | News
China-based startup InxMed raises $15 M to advance therapies for drug-resistant cancers

InxMed, a Chinese clinical-stage biotechnology company dedicated to developing innovative therapies targeting ...

May 9, 2022 | Monday | News
Texas Medical Center and Biodesign Australia join hands to enhance healthcare innovation

A major partnership between Texas Medical Center (TMC) and Biodesign Australia has been announced, aimed at advancing he...

May 9, 2022 | Monday | News
Singapore approves clinical trial of TCR-T cell therapy for liver cancer

Singapore-based SCG Cell Therapy Pte Ltd, has announced that Singapore's Health Sciences Authority (HSA) has cleared the...

May 9, 2022 | Monday | News
Korea builds deep learning model to predict adverse drug-drug interactions

The intake of multiple drugs can result in adverse health effects due to unexpected drug-drug interactions (DDIs). Now, ...

May 6, 2022 | Friday | News
Ankere Therapeutics launches with AU$10 M seed investment in Australia

A researcher from the Monash Institute of Pharmaceutical Sciences (MIPS) is a co-founder of Australian biotech company, ...

May 6, 2022 | Friday | News
AUM Biosciences inks clinical trial collaboration with Merck for colorectal cancer

Singapore-based AUM Biosciences has entered into a clinical trial collaboration and supply agreement with MSD, a tradena...

May 6, 2022 | Friday | News
Aurion Biotech raises $120 million

Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies...

May 5, 2022 | Thursday | News
Tetris Therapeutics raises $15 M in seed funding

Singapore biotechnology startup Tetris Therapeutics has raised $15 million from the funds managed by Trinity Innovation ...

May 5, 2022 | Thursday | News
APAC biotech giant Novotech acquires US CRO NCGS expanding its global expertise

Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program. Th...

May 5, 2022 | Thursday | News
NiKang Therapeutics, Hansoh Pharma ink $200M worth deal for cancer treatment in Greater China

NiKang Therapeutics , a clinical stage biotech company focused on developing innovative small molecule oncology medicine...

May 4, 2022 | Wednesday | News
Juniper Biologics inks oncology deal with Helsinn for emerging markets

Singapore-based Juniper Biologics, a science-led healthcare company focused on researching, developing and commercializi...

May 4, 2022 | Wednesday | News
ViGeneron, Daiichi Sankyo to develop novel gene therapy for prevalent eye diseases

ViGeneron GmbH, a next-generation gene therapy company, has announced a follow-on collaboration with Daiichi Sankyo Comp...

April 29, 2022 | Friday | News
WuXi, A*STAR advance cell and gene therapy in Asia-Pacific region

WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, and A*STAR's Bioprocessing Technology Institute (BTI)...

May 2, 2022 | Monday | News
China-based I-Mab appoints new COO and CMO

China's I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...

April 29, 2022 | Friday | News
Australia's Alterity Therapeutics to start phase 2 trial of neuro drug in UK

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerativ...

April 28, 2022 | Thursday | News
Japan's Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics

ERS Genomics Limited has confirmed the finalization of a license agreement with Sumitomo Pharma Co., Ltd. ("Sumitomo Pha...

April 28, 2022 | Thursday | News
Hong Kong holds first clinical trial of novel oral treatment for COVID-19

The Chinese University of Hong Kong (CUHK)’s Clinical Trial Centre has announced its collaboration with CUHK Medic...

April 28, 2022 | Thursday | News